Metabolism-Clinical and Experimental

Article	Citations
Editorial Board	619
The Conicity Index in Identification of Cardiorenal Metabolic Syndrome Patients at Increased Risk for Complications	523
EMI Not Just BMI: Unveiling Hidden Diabetes Risk Among Apparently Healthy U.S. Young Adults	400
Lifestyle and Affective Emotions in Patients with Type 2 Diabetes Mellitus, With or Without COVID-19 History	189
Comparative efficacy of Gan & Lee insulin aspart (GL-ASP) and EU-marketed insulin aspart (NN-ASP), when combined with metformin, in patients with diabetes mellitus: Post-hoc analyses from a multic	187
Characterization of Lipoprotein(a) Measurement in a Large US Healthcare Dataset	177
Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4	167
Effects of intraduodenal infusion of lauric acid and L-tryptophan, alone and combined, on glucoregulatory hormones, gastric emptying and glycaemia in healthy men	159
A Phase II, randomized, double-blind, placebo-controlled, dose-finding study of survodutide (BI 456906) in people living with overweight/obesity	155
Healthcare Professionals’ Perceptions of Obesity & Agonists of the Glucagon, GLP-1 & GIP Receptors	153
The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review	135
Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy	109
Serine active site containing protein 1 depletion alters lipid metabolism and protects against high fat diet-induced obesity in mice	108
The role of active vitamin D in preventing sarcopenia—Authors' reply	96
Brown adipose tissue-derived metabolites and their role in regulating metabolism	95
Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states	95
Hearing loss in inherited metabolic disorders: A systematic review	95
Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis	95
PCSK9 in metabolism and diseases	92
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity	89
Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake	86
PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy	86
Leveraging Automated Machine Learning to provide NAFLD screening diagnosis: Proposed machine learning models	81
Association between hypertension and severity of NAFLD among adults with obesity	75
Blood based biomarkers as non-invasive screening tools for hepatic fibrosis in subjects with Type 2 Diabetes Mellitus	74

Editorial Board	74
Editorial Board	73
Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and R	73
Corrigendum to “FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis” [Metabolism 122 (September 2021) 154840]	69
Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications	69
Risk of Obesity, Diabetes, Insulin resistance, and Dyslipidemia among Irritable Bowel Syndrome patients	67
The relationship between Vitamin D level and Sarcopenia: Insights from a Korean Population Study	65
Relationship between Obesity Indices Measured with Body Composition Analyzer and Carotid Artery Plaques in Korean Middle-Aged Men	64
Higher Resource Utilization And Mortality Among Patients With Heart Failure Admited With Diabetic Ketoacidosis And Chronic Kidney Disease	63
Uncovering mechanisms of thiazolidinediones on osteogenesis and adipogenesis using spatial fluxomics	61
Exosomes: Advances, development and potential therapeutic strategies in diabetic nephropathy	59
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19	58
Potential impact of Helicobacter pylori and metabolic syndrome-related non-alcoholic fatty liver disease on cardio-cerebrovascular disease	57
Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells	55
RETRACTED: Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease	54
Impact of fasting on the AMPK and PGC-1α axis in rodent and human skeletal muscle: A systematic review	53
Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity	53
Role of mitochondria in pathogenesis and therapy of renal fibrosis	53
Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis	50
Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis	50
Neuroprotective effect of small extracellular vesicle-mediated targeting of AMPKα2 in cerebral ischemia	49
Diabetic ketoacidosis in pediatric patients with type 1- and type 2 diabetes during the COVID-19 pandemic	49
A multi-metabolite signature robustly predicts long-term mortality in the PREDIMED trial and several US cohorts	48
Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies	48
NPRC promotes hepatic steatosis via USP30-mediated deubiquitination of C/EBPβ	48
Editorial Board	48
Editorial Board	47
Nonalcoholic fatty liver disease increases the risk of diabetes in young adults: A nationwide population-based study in Korea	47
Editorial Board	46
Real-world outcomes in people with type 2 diabetes (PWD2) and renal impairment receiving insulin glargine 300 U/mL (Gla-300) and insulin degludec 100U/mL or 200U/mL (IDeg): the DELIVER-R study	45
Clinical and Biochemical Characteristics of Children and Adolescents with Type 1 Diabetes in Mexico	44
Biological effect of nicotiflorin against acute myocardial Infarction: Therapeutic role in the medicine through scientific data analysis	44
Editorial Board	44
Biological importance of prunin in the medicine for the treatment of diabetes related complication: Therapeutic benefit through data analysis	44
Insulin Resistance as Monitored by Dynamic Light Scattering of Whole Human Serum: An Ancillary Study of PREMIER	43
Nutritional Management of Patients with Obesity in Critical Care	43
Pegozafermin Added to Background GLP-1 Therapy Led to Greater Improvement in Non-invasive Markers of Liver Fat, Injury and Fibrosis as well as Glycemic Control in NASH Patients with F2/F3 Fibrosis at	42
Endothelial sodium channel activation mediates DOCA-salt-induced endothelial cell and arterial stiffening	42
Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart	42
The LS-IM score and its relation to direct measurements of insulin resistance	42
Identifying proteins and pathways associated with multimorbidity in 53,026 adults	42
Association of eating-out rate with metabolic syndrome in Korean adults: from the Korean National Health and Nutrition Examination Survey 2016	42
Relationship between circulating adipokines and cholesterol efflux in subjects with severe carotid atherosclerosis	41
Fueling the fight against cancer: Exploring the impact of branched-chain amino acid catalyzation on cancer and cancer immune microenvironment	40
Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis	40
Editorial Board	40
Response to letter by Muralidhar and Madhivanan: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences	40
The Association Between Adiponectin and Myocardial Infarction in Patients with Nonalcoholic Fatty Liver Disease	39
T2DM Subgroups and Response to Glucose-lowering Therapy: Results from EDICT and Qatar Study	38
New PET Measures of Functional Brain Fractal Dimensions Show Significant Differences for Cortical Grey and White Matter and also in Near Normal vs. Insulin Resistant Patients	38

Fat mass paradox and carotid intima-media thickness progression: A longitudinal study from childhood through young adulthood	38
Multiple Autoimmune Syndromes in Type 1 Diabetes	38
Association Between Processed and Ultra-processed Food Intake and Cardiovascular Disease and its Risk Factors in Patients with Type 2 Diabetes	37
SACUBITRIL/VALSARTAN TREATMENT MAY BE ASSOCIATED WITH IMPROVED FRONTAL PLANE QRS-T ANGLE AND CARDIAC REPOLARIZATION PARAMETERS.	37
Olfactomedin 2 deficiency protects against diet-induced obesity	36
Corrigendum to “The RNA binding protein HuR influences skeletal muscle metabolic flexibility in rodents and humans” [Metab. 97 (2019) 40–49]	36
Omentin-1 Levels and Endothelial Dysfunction in Diabetic Kidney Disease	36
Ischemic heart failure mortality is not predicted by cardiac insulin resistance but by diabetes per se and coronary flow reserve: A retrospective dynamic cardiac 18F-FDG PET study	36
Commentary on the endocrine society clinical practice guideline on the “treatment of hypercalcemia of malignancy in adults”	36
Inverse Relationship Between Creatinine-to-Body Weight (Cre/BW) Ratio and Incident Diabetes in a Multiethnic Cohort	35
Mevalonate pathway orchestrates insulin signaling via RAB14 geranylgeranylation-mediated phosphorylation of AKT to regulate hepatic glucose metabolism	34
Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways	34
Preclinical insights into the potential of itaconate and its derivatives for liver disease therapy	33
Analysis of Cardiovascular Complications during Delivery Admissions Associated with COVID-19	33
Disrupted metabolic flux balance between pyruvate dehydrogenase and pyruvate carboxylase in human fatty liver	33
Anti-inflammatory activity of corylin in the medicine: Biological importance through scientific data analysis	33
Evaluation of renal glucose uptake with [18F]FDG-PET: Methodological advancements and metabolic outcomes	32
The mitochondrial NAD+ transporter SLC25A51 is a fasting-induced gene affecting SIRT3 functions	32
Uric Acid and Treatment With Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF): the EMPEROR-Preserved Trial	32
Prandial hepatic glucose production during hypoglycemia is altered after gastric bypass surgery and sleeve gastrectomy	32
Serum metabolomics analysis reveals increased lipid catabolism in mildly hyperbilirubinemic Gilbert's syndrome individuals	31
Recent advances and therapeutic applications of PPARγ-targeted ligands based on the inhibition mechanism of Ser273 phosphorylation	31
High levels of intracellular endotrophin in adipocytes mediate COPII vesicle supplies to autophagosome to impair autophagic flux and contribute to systemic insulin resistance in obesity	31
Females have a different metabolic response to critical illness, measured by comprehensive amino acid flux analysis	31
Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection	30
Interplay of lipid metabolism and inflammation in podocyte injury	29
O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36	29
Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis	29
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases	29
Diabetes and COVID-19: The past, the present, and the future	29
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation	28
Response to letter to the editor regarding: “Plasma metabolite profiles of meat intake and their association with cardiovascular disease risk: A population-based study in Swedish cohorts” by Arage et	28
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts	28
Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk	28
Evaluation of the effect of β-Caryophyllene on oxidative stress in BALB / c mice with streptozotocin-induced diabetes	28
Towards personalized genome-scale modeling of inborn errors of metabolism for systems medicine applications	28
Biological effect of ginkgetin on kidney injury: Health benefit in the medicine through scientific data analysis	27
New onset Diabetes Mellitus in a COVID-19 patient: A Case report	27
Weight Loss: A Changing Paradigm in Insulin Resistant and Diabetic Patients	26
The Role of Insulin Resistance in the Severity of PCOS Among a Population in Albania	26
C3aR1 on beta cells preserves beta cell function and glucose homeostasis in diabetic mice by decreasing metabolic stress and dedifferentiation	26
Editorial Board	26
Sodium-dependent Glucose Transporter 2 Inhibitor Alleviates Renal Lipid Deposition and Improves Renal Oxygenation Levels in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Randomized Controlled T	25
Revisiting gender differences in obesity and type 2 diabetes: Letter to the editor	25
Patients With Diabetic Ketoacidosis Affected By Protein Calorie Malnutrition Have In-Patient High Mortality And Increased Resource Utilization, Nation Wide Study	25
Arrestin domain containing 3 promotes alcohol-induced liver steatosis by reducing stearoyl-CoA desaturase-1 ubiquitinated degradation	25
NRH, a potent NAD+ enhancer, improves glucose homeostasis and lipid metabolism in diet-induced obese mice through an active adenosine kinase pathway	25
Effects of Semaglutide on Metabolic Syndrome Parameters in Non-Diabetics: A Meta-analysis of Randomized Controlled Trials	24
Copper impairs the intestinal barrier integrity in Wilson disease	24
Downregulation of NK cell activities in Apolipoprotein C-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cells	24
Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure	24
Dyslipidemia Correction by Combination of Statin and Choline Fenofibrate in Diabetic Patients with Multifocal Atherosclerosis	24
Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetes	23
Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled	23
Management of diabetic neuropathy	23
Renoprotective effects of genetically proxied fibroblast growth factor 21: Mendelian randomization, proteome-wide and metabolome-wide association study	23
Bone morphogenetic proteins (BMPs) in the central regulation of energy balance and adult neural plasticity	23
A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank	23
VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis	23
Sodium-glucose cotransporter-2 inhibitors: A treatment option for recurrent vasovagal syndrome?	22
Loss of metabolic adaptation in lean MAFLD is driven by endotoxemia leading to epigenetic reprogramming	22
Editorial Board	22
EFFECT OF ADMINISTRATION OF AVOCADO JUICE (PERSEA AMERICANA MILL) ON RAT-INDUCED MALONDIALDEHID (RATTUS NORVEGICUS) LEVELS	22
Propionyl-L-Carnitine in Patients with Type 2 Diabetes and Peripheral Artery Disease	22
Corrigendum to “Increased adrenal steroidogenesis and suppressed corticosteroid responsiveness in critical COVID-19” [Metabolism volume 160 (2024) 155980]	22
Acknowledgement to reviewers	22
Editorial Board	22
Role of SORT1 gene in patients with Coronary Artery Disease.	22
Targeting SAMD1 enhances the effect of anti-PD-1 plus lenvatinib therapy in hepatocellular carcinoma by increasing ferroptosis sensitivity and immune response	22
Trends in Hyperinsulinemia Among U.S. Adults without Diabetes: A Joinpoint Analysis	22
The chemokine CCL20 promotes hepatocyte cholesterol deposition during metabolic dysfunction-associated steatohepatitis by regulating OLR1 expression	22
Association of PNPLA3 and TM6SF2 Polymorphisms with NAFLD in Greek People with Type 2 Diabetes Mellitus	21
Effects of ileal glucose infusion on enteropancreatic hormone secretion in humans: relationship to glucose absorption	21
Shared genetic architecture of type 2 diabetes with muscle mass and function and frailty reveals comorbidity etiology and pleiotropic druggable targets	21
Myocardial Ischemia in Type 2 Diabetic Patients	21
Prevalence and Clinical Characteristics of Patients with Transthyretin Amyloidosis in the United States and Japan: Results from the OverTTuRe Study	21
GDF-15 improves the predictive capacity of steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignancies	21
Postpartum defects in inflammatory response after gestational diabetes precede progression to type 2 diabetes: a nested case-control study within the SWIFT study	21
Connecting nutritional deprivation and pubertal inhibition via GRK2-mediated repression of kisspeptin actions in GnRH neurons	21
Protein kinase N1 deficiency results in upregulation of cerebral energy metabolism and is highly protective in in vivo and in vitro stroke models	21

Diabetes and metabolic dysfunction-associated fatty liver disease	20
The role of histone deacetylases in cardiac energy metabolism in heart diseases	20
Deciphering the molecular pathways of saroglitazar: A dual PPAR α/γ agonist for managing metabolic NAFLD	20
Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis	20
Identifying genetic determinants of sarcopenia-related traits: a Mendelian randomization study of druggable genes	20
Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies	20
Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease	20
Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study	20
AMP deamination is sufficient to replicate an atrophy-like metabolic phenotype in skeletal muscle	20
The zebrafish model system for dyslipidemia and atherosclerosis research: Focus on environmental/exposome factors and genetic mechanisms	20
Efficacy and Safety of Tirzepatide in Type 2 Diabetes: The SURPASS Clinical Trial Program	19
Primary cilia regulate adaptive responses to fasting	19
LAT1-dependent placental methionine uptake is a key player in fetal programming of metabolic disease	19
Metabolites-mediated posttranslational modifications in cardiac metabolic remodeling: Implications for disease pathology and therapeutic potential	19
Thymoquinone: A Promising Anti-diabetic Molecule!	19
Small extracellular vesicle targeting of hypothalamic AMPKα1 promotes weight loss in leptin receptor deficient mice	19
Association of serum vitamin D level and type 2 diabetes with nonalcoholic fatty liver disease	19
Disruptive factors of treatment adherence of diabetic patients in downtown Sfax from Tunisia – a community pharmacy-based survey	19
Editorial Board	19
Value of breastfeeding in Pregnant with gestational diabetes mellitus	19
Central NUCB2/nesfatin-1 signaling ameliorates liver steatosis through suppression of endoplasmic reticulum stress in the hypothalamus	19
Insulin resistance and miR-143/miR-145 relative expression profile is associated with dysregulation in the pathological adiposity setting in aging	18
Therapeutic importance of eriodictyol in the medicine for the treatment of diabetes and associated complication through its insulin secretagogue properties	18
Corrigendum to ‘Targeting mammalian serine/threonine-protein kinase 4 through yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nep	18
New insights into the function of the NLRP3 inflammasome in sarcopenia: mechanism and therapeutic strategies	18
Telomere length of the gums of patients with diabetes mellitus in non-alcoholic fatty liver disease	18
The influence of metformin on the rate of Covid-19 vaccination among diabetes type 2 patients in Poland	18
Reply to: “Precision nutrition in aging: Enhancing frailty prevention through personalized dietary interventions”	18
Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond	18
Cytochrome P450 oxidase 2J inhibition suppresses choroidal neovascularization in mice	18
Modulation of TREM-1, Arginase and Nitric Oxide Levels under Diabetic Conditions in Macrophages	18
Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter	18
Recent advances in closed-loop insulin delivery	18
FSH exacerbates bone loss by promoting osteoclast energy metabolism through the CREB-MDH2-NAD+ axis	18
Mitochondria-SR interaction and mitochondrial fusion/fission in the regulation of skeletal muscle metabolism	17
A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: the DIRECT PLUS randomized controlled trial	17
Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation	17
Circulating α-klotho regulates metabolism via distinct central and peripheral mechanisms	17
Joint effect of blood pressure and glycemic variation on the risk of cardiovascular morbidity and mortality in persons with type 2 diabetes	17
Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis	16
Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner	16
The Association Between Gestational Diabetes Mellitus and Nonalcoholic Fatty Liver Disease: A Systematic Literature Review	16
Prognostic Fasting Insulin Cut Points for Hidden Diabetes Risk among Apparently Healthy Young Adults: CARDIA 30-year Follow Up	16
Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice	16
Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-κB pathway	16
Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control stu	16
Omega-3 Fatty Acids intervention and DASH Diet Ameliorates Metabolic profiling in Patients with Diabetes Mellitus Type 2	16
SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study	16
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus	16
A Rare Cause of Severe Insulin Resistance: A Case Report	16
EVALUATION OF 1-HOUR POST LOAD GLUCOSE LEVELS, THE METABOLIC SYNDROME AND FINDRISC SCORES IN THE PREDICTION OF T2DM IN PATIENTS WITH IMPAIRED FASTING GLUCOSE	16
Intravital imaging reveals glucose-dependent cilia movement in pancreatic islets in vivo	15
Anti-atherosclerosis activity of meranzin hydrate in the medicine: Therapeutic benefit through scientific data analysis	15
ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic treated HIV	15
Associations of single nucleotide variants of the FTO gene with metabolic disorders in children with obesity	15
TAS2R38 taste receptor gene and metabolically unhealthy obesity	15
Metabolic complications of highly active antiretroviral therapy in adult HIV-infected patients with heart failure: A 7-year prospective cohort study	15
Impaired unsaturated fatty acid elongation alters mitochondrial function and accelerates metabolic dysfunction-associated steatohepatitis progression	15
Influence of metabolic syndrome components in the course of covid-19 in patients with nonalcoholic fatty liver disease	15
FAM3A maintains metabolic homeostasis by interacting with F1-ATP synthase to regulate the activity and assembly of ATP synthase	15
Intermittent fasting and neurodegenerative diseases: Molecular mechanisms and therapeutic potential	15
Higd1a facilitates exercise-mediated alleviation of fatty liver in diet-induced obese mice	14
DR region of NKAα1 is a target to ameliorate hepatic lipid metabolism disturbance in obese mice	14
Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States	14
Circulating Total and Intact GDF-15 Levels are Not Altered in Response to Weight Loss Induced by Liraglutide and/or Lorcaserin Treatment in Humans with Obesity and/or Diabetes	14
Leptin receptor neurons in the dorsomedial hypothalamus require distinct neuronal subsets for thermogenesis and weight loss	14
REEP6 knockout leads to defective β-adrenergic signaling in adipocytes and promotes obesity-related metabolic dysfunction.	14
Early benefits of bariatric surgery on subclinical cardiac function: Contribution of visceral fat mobilization	14
Transplantation of bone marrow cells from miR150 knockout mice improves senescence-associated humoral immune dysfunction and arterial stiffness	14
From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need	14
Time-restricted eating and its impact on weight loss, adipose tissue distribution, lean mass and blood pressure in women with cardiometabolic risk factors	14
The association of circulating fibroblast growth factor 21 levels with incident heart failure: The Multi-Ethnic Study of Atherosclerosis	14
Metabolic obesity phenotypes: a friend or foe of digestive polyps?—An observational study based on National Inpatient Database	14
Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity	14
Insulin Resistance Probability Score and Cardiovascular Events in the Elderly	14
GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway	14
Liraglutide in Treatment of Diabetes Mellitus Type 2: Systematic Review and Bibliometric Analysis Over The Last Two Decades	14
Addressing the epidemic of fatty liver disease: A call to action, a call to collaboration, a call to moving the field forward	14
Association of prediabetes, diabetes, and diabetes duration with biliary tract cancer risk: A nationwide cohort study	14
Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity	13
Long Term Effectiveness of the Latest Categories of Antidiabetic Medication for Type 2 Diabetes. Outcomes of the Outpatient Diabetic Clinic of a Tertiary Hospital of Athens	13
RIPK3 causes mitochondrial dysfunction and albuminuria in diabetic podocytopathy through PGAM5-Drp1 signaling	13
Adiponectin Gene Variants and their Association with Homa-Index, Adiponectin and Leptin Levels in Adult Metabolic Syndrome Women	13
Editorial Board	13
Nitrogen oxide metabolism in the liver under conditions of systemic inflammatory response	13
Biological potential and antioxidant activity of strictinin in the medicine through literature data analysis	13
Correlation between lifestyles assessed with the FANTASTIC questionnaire and cardiovascular risk in workers of a Peruvian hospital	13
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance	13
The ubiquitin-like modifier FAT10 is induced in MASLD and impairs the lipid-regulatory activity of PPARα	13
Comprehensive molecular mechanisms and clinical therapy in nonalcoholic steatohepatitis: An overview and current perspectives	13
Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation	13
Markers of adipose tissue fibrogenesis associate with clinically significant liver fibrosis and are unchanged by synbiotic treatment in patients with NAFLD	13
High plasma and lingual uroguanylin as potential contributors to changes in food preference after sleeve gastrectomy	13
CX3CL1/CX3CR1 interaction protects against lipotoxicity-induced nonalcoholic steatohepatitis by regulating macrophage migration and M1/M2 status	13
Inhibiting IP6K1 confers atheroprotection by elevating circulating apolipoprotein A-I	13